Follow-up after treatment for melanoma skin cancer

Last medical review:

Follow-up care lets your healthcare team keep track of your health for a period of time after treatment ends. This important part of cancer care is often shared among specialists, such as the dermatologist, surgeon and oncologist, and your family doctor. They will help you recover from treatment side effects and monitor you for any signs that melanoma skin cancer has come back (recurred).

Follow-up care may not seem that important to you, especially if your treatment was long or very hard. You may find the idea of follow-up care stressful because it reminds you of your cancer experience or because you are worried about what a test might reveal. Talk to your healthcare team about how you feel and about why follow-up matters. Your healthcare team is there to help.

Schedule for follow-up visits

Don't wait until your next scheduled appointment to report any new symptoms or symptoms that don't go away. Tell your healthcare team if you have:

  • any new growths, moles or abnormal areas on your skin
  • any new lump or swelling
  • pain or an increase in pain
  • a cough that doesn't go away

The chance that melanoma will come back (recur) is greatest within 5 years, so you will need close follow-up during this time. But since melanoma can come back at any time, long-term follow-up is also important.

Follow-up visits for melanoma are usually scheduled every 3 to 12 months. It depends on the stage and the risk that the cancer will come back. If you were treated for an advanced stage of melanoma or have a high risk of recurrence, follow-up is usually done more often for the first 2 to 3 years.

Doctors usually suggest that people with a history of skin cancer have a skin exam at least once every year for the rest of their life.

During follow-up visits

During a follow-up visit, your healthcare team will usually ask questions about the side effects of treatment and how you’re coping. They will also ask about any new signs or symptoms that concern you.

Your doctor will do a physical exam, including a skin exam, to check:

  • the place where the cancer was removed or treated
  • for abnormal areas on the skin on the rest of the body, especially areas that are exposed to the sun
  • for enlarged lymph nodes close to where the cancer started

Your doctor may also teach you about:

Depending on any signs or symptoms you have or your risk that the cancer will come back, your doctor may also send you for imaging tests, such as a CT scan, an x-ray or an MRI, to check if the cancer has spread to other parts of the body.

If the cancer has come back, you and your healthcare team will discuss your treatment and care.

Find out more about follow-up

The following are questions that you can ask the healthcare team about follow-up after treatment for cancer. Choose the questions that fit your situation and add questions of your own. You may find it helpful to take the list of questions to the next appointment and to write down the answers.

  • What is the schedule for follow-up visits?
  • How often is follow-up scheduled with the cancer specialist?
  • Who is responsible for follow-up visits?
  • What will happen at a follow-up visit?
  • What tests are done on a regular basis? How often are they done?
  • Are there any symptoms that should be reported right away? Who do I call?
  • Who can help me cope with long-term side effects of treatment?

Expert review and references

  • Philip Wong, MD, MSc, MDCM, FRCPC
  • Frances Wright, MD, FRCSC
  • Keilholz U, Ascierto PA, Dummer R, et al. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee. Annals of Oncology. 2020: 31(11):1435–1448.
  • Lee CW, McKinnon JG, Davis N. Canadian melanoma conference recommendations on high-risk melanoma surveillance: a report from the 14th annual Canadian Melanoma Conference; Banff, Alberta; 20–22 February 2020. Current Oncology. 2021: 28(3):2040–2051.
  • National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology: Cutaneous Melanoma (Version 2.2023). 2023.
  • Rajagopal S, Yao X, Abadir W, et al. Guideline 8-7: Surveillance of Patients with Stage I, II, III, or Resectable IV Melanoma Who Were Treated with Curative Intent. version 2 ed. Cancer Care Ontario; 2023: https://www.cancercareontario.ca/en.
  • Ribas A, Ariyan CE, Barker CA. Cutaneous melanoma. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, chapter 63, https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.
  • Tan WW. Medscape Reference: Malignant Melanoma. 2023: https://www.medscape.com/oncology.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society